Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.
Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment....